Batch Manufacturing in the Biopharmaceutical Environment

Overview:

The operations and manufacture of biopharmaceuticals is a complex process combining the capabilities of multiple systems that extend the boundaries of batch processing. The Manufacturing Execution System (MES) receives information from the Enterprise Resource Planning (ERP) system and creates the necessary production orders, maintains material tracking/genealogy and coordinates key manual activities. The automated batch control system sequences the phases, controls the devices and captures the necessary history. These systems come together in the operation of Biopharmaceutical production plants, which require a very specific architecture that leverages standard batch products that are tightly integrated with MES capabilities. This is driven by the upstream and downstream processing specifications of such plants, the detailed compliance requirements and the benefits achieved in maximizing automated functionality. This paper explores the unique requirements of batch manufacturing in the biopharmaceutical environment.

There's More to This Story
Get more. You can read the rest of this story and other exclusive content as a Control Global community member. It's FREE, and it’s easy. We just need your name and email address. Then you can read everything you want on our site and even comment on it.

Author: Torsten Winkler, WBF

Find more white papers on Batch Management

View all white papers»